rs1554088413
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000038.6(APC):c.7512G>A(p.Trp2504*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp2504*) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 340 amino acid(s) of the APC protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 482304). This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, Invitae). This suggests that deletion of this region of the APC protein is causative of disease. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The APC c.7512G>A; p.Trp2504Ter variant (rs1554088413), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 482304). Another variant at this codon leading to the same nonsense change (c.7511G>A; p.Trp2504Ter) has been reported in individuals with familial adenomatous polyposis (FAP) (Eccles 2001, Kerr 2013). The c.7512G>A variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Additionally, several downstream truncating variants have been described in individuals with FAP and are considered disease-causing (Kerr 2013). Based on available information, the c.7512G>A; p.Trp2504Ter variant is considered to be pathogenic. References: Eccles D et al. A novel 3' mutation in the APC gene in a family presenting with a desmoid tumour. J Med Genet. 2001 Dec;38(12):861-3. PMID: 11768389. Kerr SE et al. APC germline mutations in individuals being evaluated for familial adenomatous polyposis: a review of the Mayo Clinic experience with 1591 consecutive tests. J Mol Diagn. 2013 Jan;15(1):31-43. PMID: 23159591. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W2504* pathogenic mutation (also known as c.7512G>A), located in coding exon 15 of the APC gene, results from a G to A substitution at nucleotide position 7512. This changes the amino acid from a tryptophan to a stop codon within coding exon 15. A different alteration, c.7511G>A, which is located in the same codon and results in the same protein substitution, p.W2504*, was detected in a father and daughter who had colorectal cancer and a desmoid tumor, respectively (Eccles D, et al. J. Med. Genet. 2001; 38(12):861-3). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at